Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

EyeKor, Inc. Recognized on the 2018 Inc. Magazine 5000 List of Fastest-Growing Private Companies

EyeKor, the developer behind the innovative cloud-based software platform EXCELSIOR™, is expected to revolutionize data management and drug development in the ophthalmology industry.


News provided by

EyeKor, Inc.

Aug 15, 2018, 09:50 ET

Share this article

Share toX

Share this article

Share toX


MADISON, Wis., Aug. 15, 2018 /PRNewswire-PRWeb/ -- EyeKor, Inc., a leading Software-as-a-Service (SaaS) company providing comprehensive image management and analysis for ophthalmic clinical and preclinical studies, today announced its ranking on the 2018 Inc. magazine 5000 list of the nation's fastest-growing private companies. With 1045% three-year revenue growth, EyeKor is positioned at #484, entering the prestigious circle of the top 500. To date, EyeKor has created 26 job opportunities in the State of Wisconsin.

EyeKor was founded in 2012 and developed EXCELSIOR™, its comprehensive and innovative cloud-based software platform which provides state-of-the-art solutions for the management, analysis, and interpretation of ophthalmic images in clinical trials. With extensive software functionalities for image viewing, analysis, and workflow management, EXCELSIOR™ ultimately address and solve many of the problems sponsors face throughout the drug development process by harmonizing data from different manufacturers, removing the dependency on manufacturer proprietary software, increasing the efficiency and transparency of data handling, and providing rapid turnaround time for image analysis.

“The services we provide at EyeKor...collectively enable us to be a trusted partner in the drug development industry, a role that is at the core of everything we do.” - Dr. Christopher J. Murphy, EyeKor CEO

Post this

A second version of EXCELSIOR™ has been designed and engineered specifically for the management of data in preclinical studies, enhancing comparison and translatability of data between preclinical and clinical studies, and ultimately improving and streamlining the drug development process from discovery to approval.

"Our mission at EyeKor is straightforward – to provide companies engaged in ophthalmic drug development with services and expertise that enable them to achieve their goals with optimal efficiency, while also providing an innovative technology that will help lead the industry into a new era of therapeutic development and vision care", said EyeKor's CEO, Dr. Christopher J. Murphy. "The services we provide at EyeKor, the cutting-edge functionalities provided by our EXCELSIOR™ platform, and the commitment of our team members to excellence, collectively enable us to be a trusted partner in the drug development industry, a role that is at the core of everything we do."

"The EXCELSIOR™ SaaS platform is the heart of our innovation and disruptive contribution to the field of ophthalmic drug development," added Dr. Yijun Huang, EyeKor's President and CTO. "Leveraging the benefit of cloud-based infrastructure, EXCELSIOR™ makes collaboration of stakeholders at geographically dispersed locations easier and more impactful. EXCELSIOR™ is built as a medical device with FDA 510(k) clearance and is HIPAA and 21 CFR part 11 compliant."

"The EXCELSIOR™ platform is applauded by our pharmaceutical and biotech clients in part because it can enable virtually real-time access to images and workflow progress to research teams and central reading center staff," said Dr. Ronald Danis, EyeKor's CSO and Co-Founder. "In the short time from the inception of the company, we have engaged in nearly 70 clinical trials and collected data from more than 1000 clinical sites from 42 countries. There are more than 10 million images hosted in EXCELSIOR™ to date."

For more information about EyeKor, Inc., visit https://www.eyekor.com/.

About EyeKor

EyeKor provides imaging management and analysis services for ophthalmic clinical and preclinical studies, through an innovative technology platform that allows unprecedented ability to track study progress and share image data among study stakeholders. From clinical site certification through grading data export, EyeKor can manage each step of clinical trial imaging through the unique EXCELSIOR™ platform. With EXCELSIOR™, data and images can easily be shared between clinical sites, reading centers, CROs and sponsors for maximum transparency. EXCELSIOR™ provides ease of access and workflow control to make managing global ophthalmic trials involving multiple reading centers and analysis of multiple modalities not only feasible but practical.

About Inc. 5000

The Inc. 5000 is a list of the fastest-growing private companies in the nation, compiled by Inc. Magazine annually. Started in 1982, this prestigious list of the nation's most successful private companies has become the hallmark of entrepreneurial success. EyeKor's Inc. 5000 ranking was unveiled online at Inc.com, and also in the September issue of Inc. Magazine (available on newsstands August 15th).

SOURCE EyeKor, Inc.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.